9 Sep 2016

Multiple sclerosis research update from MS Alliance

Dr Steven Petratos with his poster
The International Progressive MS Alliance published a recent project update, featuring the research of Dr Steven Petratos (pictured):
"Dr Petratos, who undertook the only Australian-led project from this round of funding, was investigating the role of a molecule called Nogo-A in nerve fibre damage in progressive MS. The researchers were aiming to block Nogo-A by delivering agents directly to the brain and spinal cord to hopefully limit MS-like disease in laboratory models of MS. The research team investigated the role of the Nogo-A related gene (known as NgR1) in nerve fibre degeneration and found that by blocking this gene they could limit nerve fibre damage and the subsequent neurodegeneration."
Related Posts Plugin for WordPress, Blogger...